nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC22A1—Latanoprost—glaucoma	0.247	0.463	CbGbCtD
Amiloride—SLC22A4—Clonidine—glaucoma	0.195	0.366	CbGbCtD
Amiloride—SLC22A1—Clonidine—glaucoma	0.0914	0.171	CbGbCtD
Amiloride—AOC1—Tryptophan metabolism—CYP1B1—glaucoma	0.00486	0.0353	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—BECN1—glaucoma	0.00421	0.0305	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—COL11A1—glaucoma	0.00412	0.0299	CbGpPWpGaD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A4—glaucoma	0.00342	0.0248	CbGpPWpGaD
Amiloride—PLAU—Complement and Coagulation Cascades—C1QB—glaucoma	0.00277	0.0201	CbGpPWpGaD
Amiloride—PLAU—Beta5 beta6 beta7 and beta8 integrin cell surface interactions—FN1—glaucoma	0.00256	0.0186	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.0023	0.0167	CbGpPWpGaD
Amiloride—PLAU—Osteopontin Signaling—MMP9—glaucoma	0.00202	0.0147	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—C3—glaucoma	0.0019	0.0138	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—TGFB2—glaucoma	0.0018	0.013	CbGpPWpGaD
Amiloride—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00179	0.013	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00174	0.0126	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—PEX19—glaucoma	0.00174	0.0126	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—PEX19—glaucoma	0.00174	0.0126	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—PEX19—glaucoma	0.00174	0.0126	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—PEX19—glaucoma	0.00174	0.0126	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—TGFB2—glaucoma	0.00168	0.0122	CbGpPWpGaD
Amiloride—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00167	0.0121	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MYLK—glaucoma	0.00162	0.0117	CbGpPWpGaD
Amiloride—PLAU—endothelium—glaucoma	0.00158	0.332	CbGeAlD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00155	0.0113	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00153	0.0111	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—glaucoma	0.00151	0.0109	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MMP2—glaucoma	0.00134	0.00975	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—MMP2—glaucoma	0.00131	0.0095	CbGpPWpGaD
Amiloride—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00131	0.00949	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—EDN1—glaucoma	0.0013	0.00942	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—CCND2—glaucoma	0.0013	0.00941	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—glaucoma	0.00124	0.00902	CbGpPWpGaD
Amiloride—SLC22A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.00124	0.009	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—FN1—glaucoma	0.00122	0.00885	CbGpPWpGaD
Amiloride—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00122	0.00885	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00118	0.00853	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00118	0.00853	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00118	0.00853	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00118	0.00853	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00118	0.00853	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—glaucoma	0.00117	0.00846	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.00116	0.0084	CbGpPWpGaD
Amiloride—SLC22A1—Amine compound SLC transporters—SLC6A13—glaucoma	0.00116	0.00839	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00115	0.00833	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—glaucoma	0.00109	0.00793	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—MMP1—glaucoma	0.00109	0.00792	CbGpPWpGaD
Amiloride—PLAU—Complement and Coagulation Cascades—C3—glaucoma	0.00108	0.00782	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—EDN1—glaucoma	0.00108	0.00781	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—glaucoma	0.00107	0.00775	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00104	0.00751	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—BCL2L1—glaucoma	0.00103	0.00749	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.00103	0.00744	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00102	0.00739	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MMP9—glaucoma	0.00101	0.00733	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—NR3C1—glaucoma	0.000985	0.00714	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—MMP9—glaucoma	0.000985	0.00714	CbGpPWpGaD
Amiloride—SLC22A2—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.000948	0.00687	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CCND2—glaucoma	0.000926	0.00672	CbGpPWpGaD
Amiloride—SLC22A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000908	0.00659	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—MMP1—glaucoma	0.000905	0.00657	CbGpPWpGaD
Amiloride—SLC9A1—RhoA signaling pathway—CDKN1B—glaucoma	0.000897	0.00651	CbGpPWpGaD
Amiloride—SLC22A1—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.000883	0.00641	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CCND2—glaucoma	0.000879	0.00637	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—glaucoma	0.000877	0.00636	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—FN1—glaucoma	0.000866	0.00628	CbGpPWpGaD
Amiloride—SLC22A1—Amine compound SLC transporters—SLC6A1—glaucoma	0.000846	0.00614	CbGpPWpGaD
Amiloride—AOC1—connective tissue—glaucoma	0.000821	0.173	CbGeAlD
Amiloride—SLC9A1—eye—glaucoma	0.000816	0.172	CbGeAlD
Amiloride—PLAU—ATF-2 transcription factor network—MMP2—glaucoma	0.000803	0.00583	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—glaucoma	0.000792	0.00575	CbGpPWpGaD
Amiloride—SLC9A1—connective tissue—glaucoma	0.000787	0.166	CbGeAlD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000785	0.00569	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000785	0.00569	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000785	0.00569	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000785	0.00569	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000785	0.00569	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000776	0.00563	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1A—glaucoma	0.000774	0.00561	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000758	0.0055	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—TNF—glaucoma	0.000758	0.0055	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000751	0.00545	CbGpPWpGaD
Amiloride—PLAU—connective tissue—glaucoma	0.000746	0.157	CbGeAlD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000746	0.00541	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—BCL2L1—glaucoma	0.000722	0.00524	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000699	0.00507	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—VEGFA—glaucoma	0.000698	0.00506	CbGpPWpGaD
Amiloride—SLC22A2—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.000694	0.00503	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.00069	0.005	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—BAD—glaucoma	0.000654	0.00475	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—MMP9—glaucoma	0.000648	0.0047	CbGpPWpGaD
Amiloride—SLC22A1—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.000647	0.00469	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CDKN2A—glaucoma	0.000642	0.00466	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CA5A—glaucoma	0.000633	0.00459	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NARFL—glaucoma	0.000633	0.00459	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—CDKN2A—glaucoma	0.000621	0.0045	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—FN1—glaucoma	0.000597	0.00433	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000575	0.00417	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000575	0.00417	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000575	0.00417	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000575	0.00417	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000575	0.00417	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—BAD—glaucoma	0.000573	0.00415	CbGpPWpGaD
Amiloride—SLC9A1—Disease—LRP12—glaucoma	0.000572	0.00415	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CDKN1B—glaucoma	0.000568	0.00412	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—MMP9—glaucoma	0.000566	0.0041	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—CDKN1B—glaucoma	0.00055	0.00399	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—MMP9—glaucoma	0.000526	0.00382	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000526	0.00381	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000518	0.00375	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—VEGFA—glaucoma	0.000508	0.00368	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—FN1—glaucoma	0.0005	0.00363	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—VEGFA—glaucoma	0.000496	0.00359	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000485	0.00352	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000466	0.00338	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN2A—glaucoma	0.000464	0.00337	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000452	0.00328	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN2A—glaucoma	0.00045	0.00327	CbGpPWpGaD
Amiloride—Tinnitus—Clonidine—glaucoma	0.000441	0.00136	CcSEcCtD
Amiloride—Headache—Methazolamide—glaucoma	0.000439	0.00136	CcSEcCtD
Amiloride—Chest pain—Pilocarpine—glaucoma	0.000439	0.00136	CcSEcCtD
Amiloride—Arthralgia—Pilocarpine—glaucoma	0.000439	0.00136	CcSEcCtD
Amiloride—Shock—Dorzolamide—glaucoma	0.000438	0.00135	CcSEcCtD
Amiloride—Paraesthesia—Acetazolamide—glaucoma	0.000436	0.00135	CcSEcCtD
Amiloride—Nausea—Levobunolol—glaucoma	0.000435	0.00134	CcSEcCtD
Amiloride—Somnolence—Acetazolamide—glaucoma	0.000432	0.00133	CcSEcCtD
Amiloride—Abdominal pain—Apraclonidine—glaucoma	0.000429	0.00133	CcSEcCtD
Amiloride—Rash—Latanoprost—glaucoma	0.000428	0.00132	CcSEcCtD
Amiloride—Dermatitis—Latanoprost—glaucoma	0.000428	0.00132	CcSEcCtD
Amiloride—Dyspepsia—Acetazolamide—glaucoma	0.000427	0.00132	CcSEcCtD
Amiloride—Headache—Latanoprost—glaucoma	0.000425	0.00131	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000425	0.00131	CcSEcCtD
Amiloride—Anorexia—Dorzolamide—glaucoma	0.000424	0.00131	CcSEcCtD
Amiloride—Confusional state—Pilocarpine—glaucoma	0.000424	0.00131	CcSEcCtD
Amiloride—Decreased appetite—Acetazolamide—glaucoma	0.000422	0.0013	CcSEcCtD
Amiloride—Insomnia—Brimonidine—glaucoma	0.000421	0.0013	CcSEcCtD
Amiloride—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000419	0.00129	CcSEcCtD
Amiloride—Bradycardia—Betaxolol—glaucoma	0.000419	0.00129	CcSEcCtD
Amiloride—Fatigue—Acetazolamide—glaucoma	0.000419	0.00129	CcSEcCtD
Amiloride—Paraesthesia—Brimonidine—glaucoma	0.000418	0.00129	CcSEcCtD
Amiloride—Alopecia—Clonidine—glaucoma	0.000418	0.00129	CcSEcCtD
Amiloride—Nausea—Methazolamide—glaucoma	0.000417	0.00129	CcSEcCtD
Amiloride—Dyspnoea—Brimonidine—glaucoma	0.000415	0.00128	CcSEcCtD
Amiloride—Somnolence—Brimonidine—glaucoma	0.000414	0.00128	CcSEcCtD
Amiloride—Shock—Pilocarpine—glaucoma	0.000414	0.00128	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN1B—glaucoma	0.000411	0.00298	CbGpPWpGaD
Amiloride—Dyspepsia—Brimonidine—glaucoma	0.00041	0.00127	CcSEcCtD
Amiloride—Angina pectoris—Timolol—glaucoma	0.000409	0.00126	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000405	0.00125	CcSEcCtD
Amiloride—Tension—Clonidine—glaucoma	0.000404	0.00125	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Travoprost—glaucoma	0.000404	0.00125	CcSEcCtD
Amiloride—Insomnia—Dorzolamide—glaucoma	0.000402	0.00124	CcSEcCtD
Amiloride—Gastrointestinal disorder—Brimonidine—glaucoma	0.000402	0.00124	CcSEcCtD
Amiloride—Fatigue—Brimonidine—glaucoma	0.000402	0.00124	CcSEcCtD
Amiloride—Anorexia—Pilocarpine—glaucoma	0.000401	0.00124	CcSEcCtD
Amiloride—Feeling abnormal—Acetazolamide—glaucoma	0.0004	0.00124	CcSEcCtD
Amiloride—Nervousness—Clonidine—glaucoma	0.0004	0.00123	CcSEcCtD
Amiloride—Paraesthesia—Dorzolamide—glaucoma	0.0004	0.00123	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN1B—glaucoma	0.000399	0.00289	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000399	0.00123	CcSEcCtD
Amiloride—Pain—Brimonidine—glaucoma	0.000398	0.00123	CcSEcCtD
Amiloride—Dyspnoea—Dorzolamide—glaucoma	0.000397	0.00123	CcSEcCtD
Amiloride—Visual impairment—Betaxolol—glaucoma	0.000397	0.00123	CcSEcCtD
Amiloride—Insomnia—Brinzolamide—glaucoma	0.000396	0.00122	CcSEcCtD
Amiloride—Somnolence—Dorzolamide—glaucoma	0.000396	0.00122	CcSEcCtD
Amiloride—Muscle spasms—Clonidine—glaucoma	0.000396	0.00122	CcSEcCtD
Amiloride—Dyspnoea—Travoprost—glaucoma	0.000395	0.00122	CcSEcCtD
Amiloride—Paraesthesia—Brinzolamide—glaucoma	0.000393	0.00121	CcSEcCtD
Amiloride—Dysuria—Timolol—glaucoma	0.000393	0.00121	CcSEcCtD
Amiloride—Dyspepsia—Dorzolamide—glaucoma	0.000392	0.00121	CcSEcCtD
Amiloride—Dyspnoea—Brinzolamide—glaucoma	0.00039	0.0012	CcSEcCtD
Amiloride—Dyspepsia—Travoprost—glaucoma	0.00039	0.0012	CcSEcCtD
Amiloride—Asthenia—Apraclonidine—glaucoma	0.000389	0.0012	CcSEcCtD
Amiloride—Somnolence—Brinzolamide—glaucoma	0.000389	0.0012	CcSEcCtD
Amiloride—Decreased appetite—Dorzolamide—glaucoma	0.000387	0.0012	CcSEcCtD
Amiloride—Erectile dysfunction—Timolol—glaucoma	0.000387	0.00119	CcSEcCtD
Amiloride—Tremor—Clonidine—glaucoma	0.000385	0.00119	CcSEcCtD
Amiloride—Dyspepsia—Brinzolamide—glaucoma	0.000385	0.00119	CcSEcCtD
Amiloride—Pruritus—Apraclonidine—glaucoma	0.000384	0.00119	CcSEcCtD
Amiloride—Fatigue—Dorzolamide—glaucoma	0.000384	0.00119	CcSEcCtD
Amiloride—Tinnitus—Betaxolol—glaucoma	0.000384	0.00119	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000383	0.00118	CcSEcCtD
Amiloride—Gastrointestinal disorder—Travoprost—glaucoma	0.000383	0.00118	CcSEcCtD
Amiloride—Fatigue—Travoprost—glaucoma	0.000382	0.00118	CcSEcCtD
Amiloride—Pain—Dorzolamide—glaucoma	0.000381	0.00118	CcSEcCtD
Amiloride—Insomnia—Pilocarpine—glaucoma	0.00038	0.00117	CcSEcCtD
Amiloride—Decreased appetite—Brinzolamide—glaucoma	0.00038	0.00117	CcSEcCtD
Amiloride—Constipation—Travoprost—glaucoma	0.000379	0.00117	CcSEcCtD
Amiloride—Pain—Travoprost—glaucoma	0.000379	0.00117	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000379	0.00275	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000378	0.00117	CcSEcCtD
Amiloride—Paraesthesia—Pilocarpine—glaucoma	0.000378	0.00117	CcSEcCtD
Amiloride—Asthenia—Bimatoprost—glaucoma	0.000378	0.00117	CcSEcCtD
Amiloride—Fatigue—Brinzolamide—glaucoma	0.000377	0.00117	CcSEcCtD
Amiloride—Dyspnoea—Pilocarpine—glaucoma	0.000375	0.00116	CcSEcCtD
Amiloride—Pain—Brinzolamide—glaucoma	0.000374	0.00116	CcSEcCtD
Amiloride—Somnolence—Pilocarpine—glaucoma	0.000374	0.00115	CcSEcCtD
Amiloride—Depression—Timolol—glaucoma	0.000373	0.00115	CcSEcCtD
Amiloride—Pruritus—Bimatoprost—glaucoma	0.000372	0.00115	CcSEcCtD
Amiloride—Diarrhoea—Apraclonidine—glaucoma	0.000371	0.00115	CcSEcCtD
Amiloride—Dyspepsia—Pilocarpine—glaucoma	0.00037	0.00114	CcSEcCtD
Amiloride—SLC9A1—Disease—HEYL—glaucoma	0.000369	0.00268	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGFR1OP—glaucoma	0.000369	0.00268	CbGpPWpGaD
Amiloride—Feeling abnormal—Dorzolamide—glaucoma	0.000367	0.00113	CcSEcCtD
Amiloride—Decreased appetite—Pilocarpine—glaucoma	0.000366	0.00113	CcSEcCtD
Amiloride—Feeling abnormal—Travoprost—glaucoma	0.000365	0.00113	CcSEcCtD
Amiloride—Gastrointestinal pain—Dorzolamide—glaucoma	0.000364	0.00112	CcSEcCtD
Amiloride—Alopecia—Betaxolol—glaucoma	0.000364	0.00112	CcSEcCtD
Amiloride—Palpitations—Clonidine—glaucoma	0.000364	0.00112	CcSEcCtD
Amiloride—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000363	0.00112	CcSEcCtD
Amiloride—Gastrointestinal pain—Travoprost—glaucoma	0.000362	0.00112	CcSEcCtD
Amiloride—Feeling abnormal—Brinzolamide—glaucoma	0.000361	0.00111	CcSEcCtD
Amiloride—Constipation—Pilocarpine—glaucoma	0.00036	0.00111	CcSEcCtD
Amiloride—Pain—Pilocarpine—glaucoma	0.00036	0.00111	CcSEcCtD
Amiloride—Cough—Clonidine—glaucoma	0.000359	0.00111	CcSEcCtD
Amiloride—Dizziness—Apraclonidine—glaucoma	0.000359	0.00111	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—TP53—glaucoma	0.000357	0.00259	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000355	0.00258	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000355	0.00257	CbGpPWpGaD
Amiloride—Abdominal pain—Dorzolamide—glaucoma	0.000352	0.00109	CcSEcCtD
Amiloride—Tension—Betaxolol—glaucoma	0.000352	0.00109	CcSEcCtD
Amiloride—Chest pain—Clonidine—glaucoma	0.00035	0.00108	CcSEcCtD
Amiloride—Arthralgia—Clonidine—glaucoma	0.00035	0.00108	CcSEcCtD
Amiloride—Abdominal pain—Travoprost—glaucoma	0.00035	0.00108	CcSEcCtD
Amiloride—Asthenia—Acetazolamide—glaucoma	0.000348	0.00108	CcSEcCtD
Amiloride—Dizziness—Bimatoprost—glaucoma	0.000348	0.00108	CcSEcCtD
Amiloride—Nervousness—Betaxolol—glaucoma	0.000348	0.00107	CcSEcCtD
Amiloride—Feeling abnormal—Pilocarpine—glaucoma	0.000347	0.00107	CcSEcCtD
Amiloride—Vomiting—Apraclonidine—glaucoma	0.000345	0.00107	CcSEcCtD
Amiloride—Muscle spasms—Betaxolol—glaucoma	0.000344	0.00106	CcSEcCtD
Amiloride—Gastrointestinal pain—Pilocarpine—glaucoma	0.000344	0.00106	CcSEcCtD
Amiloride—Bradycardia—Timolol—glaucoma	0.000342	0.00106	CcSEcCtD
Amiloride—Dermatitis—Apraclonidine—glaucoma	0.000342	0.00106	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000341	0.00247	CbGpPWpGaD
Amiloride—Headache—Apraclonidine—glaucoma	0.00034	0.00105	CcSEcCtD
Amiloride—Confusional state—Clonidine—glaucoma	0.000339	0.00105	CcSEcCtD
Amiloride—Tremor—Betaxolol—glaucoma	0.000336	0.00104	CcSEcCtD
Amiloride—Asthenia—Brimonidine—glaucoma	0.000334	0.00103	CcSEcCtD
Amiloride—Abdominal pain—Pilocarpine—glaucoma	0.000332	0.00103	CcSEcCtD
Amiloride—Diarrhoea—Acetazolamide—glaucoma	0.000332	0.00103	CcSEcCtD
Amiloride—Rash—Bimatoprost—glaucoma	0.000332	0.00103	CcSEcCtD
Amiloride—Dermatitis—Bimatoprost—glaucoma	0.000331	0.00102	CcSEcCtD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000331	0.0024	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00033	0.0024	CbGpPWpGaD
Amiloride—Shock—Clonidine—glaucoma	0.00033	0.00102	CcSEcCtD
Amiloride—Pruritus—Brimonidine—glaucoma	0.00033	0.00102	CcSEcCtD
Amiloride—Headache—Bimatoprost—glaucoma	0.00033	0.00102	CcSEcCtD
Amiloride—Visual impairment—Timolol—glaucoma	0.000324	0.001	CcSEcCtD
Amiloride—Nausea—Apraclonidine—glaucoma	0.000322	0.000996	CcSEcCtD
Amiloride—Vertigo—Betaxolol—glaucoma	0.000322	0.000994	CcSEcCtD
Amiloride—PLAU—Hemostasis—TGFB2—glaucoma	0.000322	0.00233	CbGpPWpGaD
Amiloride—Dizziness—Acetazolamide—glaucoma	0.000321	0.000992	CcSEcCtD
Amiloride—Anorexia—Clonidine—glaucoma	0.00032	0.000989	CcSEcCtD
Amiloride—Asthenia—Dorzolamide—glaucoma	0.000319	0.000986	CcSEcCtD
Amiloride—Asthenia—Travoprost—glaucoma	0.000318	0.000982	CcSEcCtD
Amiloride—Palpitations—Betaxolol—glaucoma	0.000317	0.000978	CcSEcCtD
Amiloride—Pruritus—Dorzolamide—glaucoma	0.000315	0.000973	CcSEcCtD
Amiloride—Asthenia—Brinzolamide—glaucoma	0.000314	0.00097	CcSEcCtD
Amiloride—Pruritus—Travoprost—glaucoma	0.000313	0.000968	CcSEcCtD
Amiloride—Tinnitus—Timolol—glaucoma	0.000313	0.000968	CcSEcCtD
Amiloride—Cough—Betaxolol—glaucoma	0.000313	0.000966	CcSEcCtD
Amiloride—Nausea—Bimatoprost—glaucoma	0.000313	0.000966	CcSEcCtD
Amiloride—Pruritus—Brinzolamide—glaucoma	0.00031	0.000956	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CA1—glaucoma	0.000309	0.00224	CbGpPWpGaD
Amiloride—Vomiting—Acetazolamide—glaucoma	0.000309	0.000954	CcSEcCtD
Amiloride—Dizziness—Brimonidine—glaucoma	0.000308	0.000952	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000308	0.00223	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Clonidine—glaucoma	0.000306	0.000945	CcSEcCtD
Amiloride—Arthralgia—Betaxolol—glaucoma	0.000305	0.000942	CcSEcCtD
Amiloride—Chest pain—Betaxolol—glaucoma	0.000305	0.000942	CcSEcCtD
Amiloride—Diarrhoea—Dorzolamide—glaucoma	0.000304	0.000941	CcSEcCtD
Amiloride—Headache—Acetazolamide—glaucoma	0.000304	0.00094	CcSEcCtD
Amiloride—Insomnia—Clonidine—glaucoma	0.000304	0.000938	CcSEcCtD
Amiloride—Diarrhoea—Travoprost—glaucoma	0.000303	0.000937	CcSEcCtD
Amiloride—Asthenia—Pilocarpine—glaucoma	0.000302	0.000932	CcSEcCtD
Amiloride—Paraesthesia—Clonidine—glaucoma	0.000302	0.000931	CcSEcCtD
Amiloride—Dyspnoea—Clonidine—glaucoma	0.000299	0.000925	CcSEcCtD
Amiloride—Diarrhoea—Brinzolamide—glaucoma	0.000299	0.000925	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CTSA—glaucoma	0.000299	0.00217	CbGpPWpGaD
Amiloride—Somnolence—Clonidine—glaucoma	0.000299	0.000922	CcSEcCtD
Amiloride—Pruritus—Pilocarpine—glaucoma	0.000298	0.000919	CcSEcCtD
Amiloride—Alopecia—Timolol—glaucoma	0.000297	0.000918	CcSEcCtD
Amiloride—Confusional state—Betaxolol—glaucoma	0.000295	0.000911	CcSEcCtD
Amiloride—Dizziness—Dorzolamide—glaucoma	0.000294	0.000909	CcSEcCtD
Amiloride—Rash—Brimonidine—glaucoma	0.000294	0.000908	CcSEcCtD
Amiloride—Dermatitis—Brimonidine—glaucoma	0.000294	0.000907	CcSEcCtD
Amiloride—Dizziness—Travoprost—glaucoma	0.000293	0.000905	CcSEcCtD
Amiloride—Headache—Brimonidine—glaucoma	0.000292	0.000902	CcSEcCtD
Amiloride—Decreased appetite—Clonidine—glaucoma	0.000292	0.000902	CcSEcCtD
Amiloride—Gastrointestinal disorder—Clonidine—glaucoma	0.00029	0.000896	CcSEcCtD
Amiloride—Fatigue—Clonidine—glaucoma	0.00029	0.000894	CcSEcCtD
Amiloride—Dizziness—Brinzolamide—glaucoma	0.000289	0.000894	CcSEcCtD
Amiloride—Nausea—Acetazolamide—glaucoma	0.000288	0.000891	CcSEcCtD
Amiloride—Diarrhoea—Pilocarpine—glaucoma	0.000288	0.000889	CcSEcCtD
Amiloride—Shock—Betaxolol—glaucoma	0.000288	0.000889	CcSEcCtD
Amiloride—Tension—Timolol—glaucoma	0.000287	0.000887	CcSEcCtD
Amiloride—Constipation—Clonidine—glaucoma	0.000287	0.000887	CcSEcCtD
Amiloride—Pain—Clonidine—glaucoma	0.000287	0.000887	CcSEcCtD
Amiloride—Nervousness—Timolol—glaucoma	0.000284	0.000878	CcSEcCtD
Amiloride—Vomiting—Dorzolamide—glaucoma	0.000283	0.000874	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CA2—glaucoma	0.000283	0.00205	CbGpPWpGaD
Amiloride—Rash—Dorzolamide—glaucoma	0.000281	0.000867	CcSEcCtD
Amiloride—Dermatitis—Dorzolamide—glaucoma	0.00028	0.000866	CcSEcCtD
Amiloride—Rash—Travoprost—glaucoma	0.000279	0.000863	CcSEcCtD
Amiloride—Dermatitis—Travoprost—glaucoma	0.000279	0.000862	CcSEcCtD
Amiloride—Headache—Dorzolamide—glaucoma	0.000279	0.000861	CcSEcCtD
Amiloride—Anorexia—Betaxolol—glaucoma	0.000279	0.000861	CcSEcCtD
Amiloride—Vomiting—Brinzolamide—glaucoma	0.000278	0.000859	CcSEcCtD
Amiloride—Dizziness—Pilocarpine—glaucoma	0.000278	0.000859	CcSEcCtD
Amiloride—Headache—Travoprost—glaucoma	0.000278	0.000858	CcSEcCtD
Amiloride—Nausea—Brimonidine—glaucoma	0.000277	0.000855	CcSEcCtD
Amiloride—Feeling abnormal—Clonidine—glaucoma	0.000277	0.000855	CcSEcCtD
Amiloride—Rash—Brinzolamide—glaucoma	0.000276	0.000852	CcSEcCtD
Amiloride—Dermatitis—Brinzolamide—glaucoma	0.000276	0.000851	CcSEcCtD
Amiloride—Gastrointestinal pain—Clonidine—glaucoma	0.000275	0.000848	CcSEcCtD
Amiloride—Headache—Brinzolamide—glaucoma	0.000274	0.000847	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000272	0.00197	CbGpPWpGaD
Amiloride—Vomiting—Pilocarpine—glaucoma	0.000267	0.000826	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000266	0.000823	CcSEcCtD
Amiloride—Abdominal pain—Clonidine—glaucoma	0.000265	0.00082	CcSEcCtD
Amiloride—Rash—Pilocarpine—glaucoma	0.000265	0.000819	CcSEcCtD
Amiloride—Dermatitis—Pilocarpine—glaucoma	0.000265	0.000818	CcSEcCtD
Amiloride—Insomnia—Betaxolol—glaucoma	0.000264	0.000817	CcSEcCtD
Amiloride—Nausea—Dorzolamide—glaucoma	0.000264	0.000817	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—glaucoma	0.000264	0.00192	CbGpPWpGaD
Amiloride—Headache—Pilocarpine—glaucoma	0.000263	0.000814	CcSEcCtD
Amiloride—Nausea—Travoprost—glaucoma	0.000263	0.000813	CcSEcCtD
Amiloride—Vertigo—Timolol—glaucoma	0.000263	0.000812	CcSEcCtD
Amiloride—Paraesthesia—Betaxolol—glaucoma	0.000263	0.000811	CcSEcCtD
Amiloride—Dyspnoea—Betaxolol—glaucoma	0.000261	0.000805	CcSEcCtD
Amiloride—Nausea—Brinzolamide—glaucoma	0.00026	0.000803	CcSEcCtD
Amiloride—Palpitations—Timolol—glaucoma	0.000259	0.000799	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—glaucoma	0.000258	0.00187	CbGpPWpGaD
Amiloride—Dyspepsia—Betaxolol—glaucoma	0.000257	0.000795	CcSEcCtD
Amiloride—Cough—Timolol—glaucoma	0.000255	0.000789	CcSEcCtD
Amiloride—Decreased appetite—Betaxolol—glaucoma	0.000254	0.000785	CcSEcCtD
Amiloride—SLC22A1—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000253	0.00184	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Betaxolol—glaucoma	0.000252	0.00078	CcSEcCtD
Amiloride—Fatigue—Betaxolol—glaucoma	0.000252	0.000779	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—glaucoma	0.000251	0.00182	CbGpPWpGaD
Amiloride—Constipation—Betaxolol—glaucoma	0.00025	0.000772	CcSEcCtD
Amiloride—Pain—Betaxolol—glaucoma	0.00025	0.000772	CcSEcCtD
Amiloride—Nausea—Pilocarpine—glaucoma	0.00025	0.000772	CcSEcCtD
Amiloride—Chest pain—Timolol—glaucoma	0.000249	0.00077	CcSEcCtD
Amiloride—Arthralgia—Timolol—glaucoma	0.000249	0.00077	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000249	0.0018	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SOD1—glaucoma	0.000244	0.00177	CbGpPWpGaD
Amiloride—Asthenia—Clonidine—glaucoma	0.000241	0.000744	CcSEcCtD
Amiloride—Feeling abnormal—Betaxolol—glaucoma	0.000241	0.000744	CcSEcCtD
Amiloride—Confusional state—Timolol—glaucoma	0.000241	0.000744	CcSEcCtD
Amiloride—Pruritus—Clonidine—glaucoma	0.000238	0.000734	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000237	0.00172	CbGpPWpGaD
Amiloride—Shock—Timolol—glaucoma	0.000235	0.000726	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000232	0.00168	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HDAC9—glaucoma	0.00023	0.00167	CbGpPWpGaD
Amiloride—Diarrhoea—Clonidine—glaucoma	0.00023	0.00071	CcSEcCtD
Amiloride—Anorexia—Timolol—glaucoma	0.000228	0.000703	CcSEcCtD
Amiloride—Dizziness—Clonidine—glaucoma	0.000222	0.000686	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00022	0.0016	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Timolol—glaucoma	0.000218	0.000672	CcSEcCtD
Amiloride—Insomnia—Timolol—glaucoma	0.000216	0.000667	CcSEcCtD
Amiloride—Paraesthesia—Timolol—glaucoma	0.000214	0.000663	CcSEcCtD
Amiloride—Vomiting—Clonidine—glaucoma	0.000214	0.00066	CcSEcCtD
Amiloride—Dyspnoea—Timolol—glaucoma	0.000213	0.000658	CcSEcCtD
Amiloride—Somnolence—Timolol—glaucoma	0.000212	0.000656	CcSEcCtD
Amiloride—Rash—Clonidine—glaucoma	0.000212	0.000654	CcSEcCtD
Amiloride—Dermatitis—Clonidine—glaucoma	0.000212	0.000653	CcSEcCtD
Amiloride—Headache—Clonidine—glaucoma	0.00021	0.00065	CcSEcCtD
Amiloride—Dyspepsia—Timolol—glaucoma	0.00021	0.000649	CcSEcCtD
Amiloride—Asthenia—Betaxolol—glaucoma	0.00021	0.000648	CcSEcCtD
Amiloride—SLC22A2—Neuronal System—SLC6A13—glaucoma	0.000208	0.00151	CbGpPWpGaD
Amiloride—Decreased appetite—Timolol—glaucoma	0.000208	0.000641	CcSEcCtD
Amiloride—Pruritus—Betaxolol—glaucoma	0.000207	0.000639	CcSEcCtD
Amiloride—Gastrointestinal disorder—Timolol—glaucoma	0.000206	0.000637	CcSEcCtD
Amiloride—Fatigue—Timolol—glaucoma	0.000206	0.000636	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000205	0.00149	CbGpPWpGaD
Amiloride—Pain—Timolol—glaucoma	0.000204	0.000631	CcSEcCtD
Amiloride—Diarrhoea—Betaxolol—glaucoma	0.0002	0.000618	CcSEcCtD
Amiloride—Nausea—Clonidine—glaucoma	0.000199	0.000616	CcSEcCtD
Amiloride—SLC9A1—Metabolism—TXN—glaucoma	0.000199	0.00144	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000199	0.00144	CbGpPWpGaD
Amiloride—Feeling abnormal—Timolol—glaucoma	0.000197	0.000608	CcSEcCtD
Amiloride—Gastrointestinal pain—Timolol—glaucoma	0.000195	0.000603	CcSEcCtD
Amiloride—SLC22A1—Neuronal System—SLC6A13—glaucoma	0.000194	0.00141	CbGpPWpGaD
Amiloride—Dizziness—Betaxolol—glaucoma	0.000193	0.000597	CcSEcCtD
Amiloride—Abdominal pain—Timolol—glaucoma	0.000189	0.000583	CcSEcCtD
Amiloride—PLAU—Hemostasis—MMP1—glaucoma	0.000186	0.00135	CbGpPWpGaD
Amiloride—Vomiting—Betaxolol—glaucoma	0.000186	0.000574	CcSEcCtD
Amiloride—SLC22A1—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000186	0.00135	CbGpPWpGaD
Amiloride—Rash—Betaxolol—glaucoma	0.000184	0.000569	CcSEcCtD
Amiloride—Dermatitis—Betaxolol—glaucoma	0.000184	0.000569	CcSEcCtD
Amiloride—Headache—Betaxolol—glaucoma	0.000183	0.000566	CcSEcCtD
Amiloride—PLAU—Hemostasis—CAV1—glaucoma	0.000178	0.00129	CbGpPWpGaD
Amiloride—Nausea—Betaxolol—glaucoma	0.000174	0.000536	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000173	0.00126	CbGpPWpGaD
Amiloride—Asthenia—Timolol—glaucoma	0.000171	0.000529	CcSEcCtD
Amiloride—PLAU—Hemostasis—FN1—glaucoma	0.00017	0.00123	CbGpPWpGaD
Amiloride—Pruritus—Timolol—glaucoma	0.000169	0.000522	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000168	0.00122	CbGpPWpGaD
Amiloride—Diarrhoea—Timolol—glaucoma	0.000163	0.000505	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000161	0.00117	CbGpPWpGaD
Amiloride—Dizziness—Timolol—glaucoma	0.000158	0.000488	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000157	0.00114	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTT1—glaucoma	0.000154	0.00112	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—SLC6A1—glaucoma	0.000153	0.00111	CbGpPWpGaD
Amiloride—Vomiting—Timolol—glaucoma	0.000152	0.000469	CcSEcCtD
Amiloride—Rash—Timolol—glaucoma	0.000151	0.000465	CcSEcCtD
Amiloride—Dermatitis—Timolol—glaucoma	0.00015	0.000465	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00015	0.00109	CbGpPWpGaD
Amiloride—Headache—Timolol—glaucoma	0.00015	0.000462	CcSEcCtD
Amiloride—SLC22A1—Neuronal System—SLC6A1—glaucoma	0.000142	0.00103	CbGpPWpGaD
Amiloride—Nausea—Timolol—glaucoma	0.000142	0.000438	CcSEcCtD
Amiloride—SLC22A2—Metabolism—NARFL—glaucoma	0.000137	0.000993	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA5A—glaucoma	0.000137	0.000993	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS3—glaucoma	0.000135	0.000978	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NARFL—glaucoma	0.000128	0.000926	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA5A—glaucoma	0.000128	0.000926	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN2B—glaucoma	0.000124	0.000898	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCA1—glaucoma	0.000123	0.000892	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1B1—glaucoma	0.000123	0.000892	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000112	0.000813	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000104	0.000757	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTHFR—glaucoma	0.000104	0.000753	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTM1—glaucoma	9.83e-05	0.000713	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—glaucoma	9.71e-05	0.000705	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOE—glaucoma	9.66e-05	0.000701	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CAV1—glaucoma	9.57e-05	0.000694	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BAD—glaucoma	9e-05	0.000653	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—glaucoma	8.69e-05	0.00063	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.2e-05	0.000595	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—glaucoma	8.09e-05	0.000587	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CAV1—glaucoma	8.02e-05	0.000581	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.64e-05	0.000554	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—glaucoma	7.34e-05	0.000532	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—glaucoma	7.24e-05	0.000525	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA1—glaucoma	6.69e-05	0.000485	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—glaucoma	6.62e-05	0.00048	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CTSA—glaucoma	6.48e-05	0.00047	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—glaucoma	6.27e-05	0.000455	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA1—glaucoma	6.23e-05	0.000452	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA2—glaucoma	6.12e-05	0.000444	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—glaucoma	6.06e-05	0.00044	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CTSA—glaucoma	6.04e-05	0.000438	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA2—glaucoma	5.7e-05	0.000413	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—glaucoma	5.54e-05	0.000402	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TXN—glaucoma	4.31e-05	0.000313	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TXN—glaucoma	4.02e-05	0.000291	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—glaucoma	3.34e-05	0.000242	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—glaucoma	3.11e-05	0.000226	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCA1—glaucoma	2.66e-05	0.000193	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1B1—glaucoma	2.66e-05	0.000193	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCA1—glaucoma	2.48e-05	0.00018	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1B1—glaucoma	2.48e-05	0.00018	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—glaucoma	2.13e-05	0.000154	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—glaucoma	1.98e-05	0.000144	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—glaucoma	1.88e-05	0.000136	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—glaucoma	1.75e-05	0.000127	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—glaucoma	1.75e-05	0.000127	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAV1—glaucoma	1.73e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—glaucoma	1.63e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAV1—glaucoma	1.62e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—glaucoma	1.31e-05	9.51e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—glaucoma	1.22e-05	8.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—glaucoma	1.2e-05	8.7e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—glaucoma	1.12e-05	8.11e-05	CbGpPWpGaD
